Sunovion Respiratory Development

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Sunovion Respiratory Development sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 7 completed upper quartile by trial count

Sunovion Respiratory Development: 7 sponsored US clinical trials, none currently recruiting.

Sunovion Respiratory Development sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 4 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Obstructive Pulmonary Disease (COPD), with 2 trials.

Upper-quartile sponsor footprint

Sunovion Respiratory Development sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

COMPLETED Phase 4

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

NCT04155047
COMPLETED Phase 3

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)

NCT02347774
COMPLETED Phase 3

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD

NCT02347761
COMPLETED Phase 3

A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD

NCT02276222
COMPLETED Phase 2

A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD

NCT02038829
COMPLETED Phase 2

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT01706536
COMPLETED Phase 2

Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study

NCT01426009

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 3
Phase 4 1

Therapeutic Areas

Chronic Obstructive Pulmonary Disease (COPD) 2

How the Sunovion Respiratory Development archive is shaped

7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).

Phase mix: 4 late (III/IV) vs 3 early (I/II) (balanced across stages).

Top condition: Chronic Obstructive Pulmonary Disease (COPD) (2 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Sunovion Respiratory Development: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Sunovion Respiratory Development sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Sunovion Respiratory Development3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
Sunovion Respiratory Development sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Sunovion Respiratory Development sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Sunovion Respiratory Development page

7 registered trials is a research-attention snapshot, not an endorsement of Sunovion Respiratory Development or any single study.

  • None of Sunovion Respiratory Development's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Chronic Obstructive Pulmonary Disease (COPD) is the condition Sunovion Respiratory Development studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Obstructive Pulmonary Disease (COPD) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Sunovion Respiratory Development pipeline card: 7 registered trials from official public datasets.Report a data error.